Anderson Orthopaedic Research Institute is located in Alexandria, VA. The organization was established in 1973. According to its NTEE Classification (G05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. As of 05/2022, Anderson Orthopaedic Research Institute employed 12 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Anderson Orthopaedic Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 05/2022, Anderson Orthopaedic Research Institute generated $2.6m in total revenue. This organization has experienced exceptional growth, as over the past 7 years, it has increased revenue by an average of 12.2% each year . All expenses for the organization totaled $935.8k during the year ending 05/2022. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2022
Describe the Organization's Mission:
Part 3 - Line 1
TO CONDUCT SCIENTIFIC RESEARCH AND EDUCATE HEALTH CARE PROFESSIONALS IN ORTHOPAEDICS & RHEUMATOLOGY
Describe the Organization's Program Activity:
Part 3 - Line 4a
THE FUNDING RECEIVED BY THE ANDERSON ORTHOPAEDIC RESEARCH INSTITUTE (AORI) IS USED TO CONDUCT MEDICAL RESEARCH RELATED TO HIP, KNEE AND SHOULDER JOINT REPLACEMENTS. AORI CONDUCTS BOTH PROSPECTIVE AND RETROSPECTIVE STUDIES WITH THE ULTIMATE GOAL OF SHARING RESEARCH FINDINGS WITH THE BROADER MEDICAL COMMUNITY, INCLUDING PATIENTS, THROUGH PUBLICATIONS AND PRESENTATIONS. PROSPECTIVE STUDIES, WHERE VOLUNTEERS CONSENT TO PARTICIPATE, ARE MANAGED BY AORI'S CLINICAL RESEARCH STAFF. THESE STAFF MEMBERS HELP DESIGN STUDY PROTOCOLS, OBTAIN INSTITUTIONAL REVIEW BOARD APPROVAL, CONSENT PATIENTS, MANAGE DATA COLLECTION, SCHEDULE FOLLOW-UP VISITS, ANALYZE OUTCOME DATA AND SUMMARIZE THE RESEARCH RESULTS FOR STUDY SPONSORS AND PEER-REVIEW JOURNAL PUBLICATIONS. RETROSPECTIVE STUDIES, WHICH USE PRE-EXISTING MEDICAL DATA, ARE CONDUCTED USING AORI'S ELECTRONIC OUTCOMES DATABASE THAT ARCHIVES SURGICAL PROCEDURES, CLINICAL VISITS AND ADVERSE EVENTS. BY ANALYZING THE DATA ARCHIVED IN AORI'S INSTITUTIONAL DATABASE, AORI STAFF MEMBERS ARE ABLE TO ASSESS THE OUTCOME OF DIFFERENT TYPES OF IMPLANTS AMONG UNIQUE GROUPS OF PATIENTS. THE FUNDING RECEIVED BY AORI SUPPORTS STAFF SALARIES AND BENEFITS, PAYS FOR LABORATORY SUPPLIES AND CLINICAL TESTS THAT ARE NOT STANDARD-OF-CARE, AND IS USED FOR FEES CHARGED BY AGENCIES THAT OVERSEE AORI'S RESEARCH ACTIVITIES. ASSETS SUCH AS COMPUTERS, LABORATORY TESTING EQUIPMENT AND ANALYSIS SOFTWARE ARE ALSO PURCHASED WITH THE FUNDS RECEIVED BY AORI. FUNDING IS ALSO USED TO PRODUCE A PERIODIC NEWSLETTER THAT IS MAILED OUT TO APPROXIMATELY 29,000 PEOPLE. DURING THE PAST YEAR, AORI-AFFILIATED RESEARCHERS PUBLISHED 22 PAPERS IN ORTHOPAEDIC JOURNALS AND 2 BOOK CHAPTERS. AORI RESEARCHERS ALSO PRESENTED 28 SCIENTIFIC TALKS AND 9 POSTERS AT NATIONAL AND INTERNATIONAL ORTHOPAEDIC MEETINGS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Robert Hopper Jr Executive Director | Officer | 40 | $129,625 |
Nancy Parks Sr. Project Director | 40 | $128,535 | |
Supatra Sritulanondha Clinical Researcher | 40 | $116,275 | |
Henry Ho Sr. Project Director | 40 | $115,051 | |
Susan Sensi Administrator | 40 | $104,537 | |
C Anderson Engh Jr Medical Director/trustee | OfficerTrustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $574,923 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $574,923 |
Total Program Service Revenue | $13,175 |
Investment income | $201,290 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $1,765,768 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,555,156 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $165,544 |
Compensation of current officers, directors, key employees. | $25,936 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $564,810 |
Pension plan accruals and contributions | $0 |
Other employee benefits | $39,307 |
Payroll taxes | $52,987 |
Fees for services: Management | $0 |
Fees for services: Legal | $414 |
Fees for services: Accounting | $7,500 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $64,841 |
Fees for services: Other | $37,848 |
Advertising and promotion | $0 |
Office expenses | $18,408 |
Information technology | $0 |
Royalties | $0 |
Occupancy | $66,592 |
Travel | $1,068 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
Conferences, conventions, and meetings | $3,610 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $1,797 |
Insurance | $6,310 |
All other expenses | -$148,079 |
Total functional expenses | $935,790 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $750,450 |
Savings and temporary cash investments | $0 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $0 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $0 |
Net Land, buildings, and equipment | $1,487 |
Investments—publicly traded securities | $0 |
Investments—other securities | $12,902,824 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $2,314 |
Total assets | $13,657,075 |
Accounts payable and accrued expenses | $0 |
Grants payable | $131,514 |
Deferred revenue | $0 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $131,514 |
Net assets without donor restrictions | $9,096,283 |
Net assets with donor restrictions | $4,429,278 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $13,657,075 |
Over the last fiscal year, we have identified 3 grants that Anderson Orthopaedic Research Institute has recieved totaling $36,342.
Awarding Organization | Amount |
---|---|
Mary Hitchcock Memorial Hospital Lebanon, NH PURPOSE: CHARITABLE RESEARCH | $12,114 |
Mary Hitchcock Memorial Hospital Lebanon, NH PURPOSE: CHARITABLE RESEARCH | $12,114 |
Mary Hitchcock Memorial Hospital Lebanon, NH PURPOSE: CHARITABLE RESEARCH | $12,114 |
Beg. Balance | $4,504,216 |
Earnings | -$145,700 |
Admin Expense | $21,835 |
Net Contributions | $92,598 |
Ending Balance | $4,429,278 |
Organization Name | Assets | Revenue |
---|---|---|
Personalized Medicine Coalition Washington, DC | $3,140,765 | $2,833,639 |
Anderson Orthopaedic Research Institute Alexandria, VA | $13,657,075 | $2,555,156 |
Biotechnology Institute Washington, DC | $332,875 | $775,500 |
Diabetes Patient Advocacy Coalition Lexington, KY | $840,273 | $540,959 |
Tennessee Breast Cancer Coalition Inc Franklin, TN | $487,322 | $294,896 |
United States Cutaneous Lymphoma Consortium Nashville, TN | $540,921 | $99,933 |